Related Experiment Video
Updated: Feb 19, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
G2/M-Phase Checkpoint Adaptation and Micronuclei Formation as Mechanisms That Contribute to Genomic Instability in
Danî Kalsbeek1, Roy M Golsteyn2
1Cancer Cell Laboratory, Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. dani.kalsbeek@uleth.ca.
Abstract:
One of the most common characteristics of cancer cells is genomic instability. Recent research has revealed that G2/M-phase checkpoint adaptation-entering mitosis with damaged DNA-contributes to genomic changes in experimental models. When cancer cells are treated with pharmacological concentrations of genotoxic agents, they undergo checkpoint adaptation; however, a small number of cells are able to survive and accumulate micronuclei. These micronuclei harbour damaged DNA, and are able to replicate and reincorporate their DNA into the main nucleus. Micronuclei are susceptible to chromothripsis, which is a phenomenon characterised by extensively rearranged chromosomes that reassemble from pulverized chromosomes in one cellular event. These processes contribute to genomic instability in cancer cells that survive a genotoxic anti-cancer treatment. This review provides insight into checkpoint adaptation and its connection to micronuclei and possibly chromothripsis. Knowledge about these mechanisms is needed to improve the poor cancer treatment outcomes that result from genomic instability.
Insights
Cancer cells adapt to DNA damage by entering mitosis with errors, leading to genomic instability. This review explores how checkpoint adaptation, micronuclei, and chromothripsis drive cancer evolution and treatment resistance.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Genomic instability is a hallmark of cancer.
- G2/M-phase checkpoint adaptation, where cells enter mitosis with damaged DNA, contributes to genomic alterations.
- This process is observed in cancer cells treated with genotoxic agents.
Purpose of the Study:
- To review the mechanisms of G2/M-phase checkpoint adaptation in cancer.
- To explore the link between checkpoint adaptation, micronuclei formation, and chromothripsis.
- To highlight the role of these processes in driving genomic instability and treatment resistance.
Main Methods:
- Literature review of studies on cancer cell response to genotoxic agents.
- Analysis of mechanisms involving G2/M-phase checkpoint adaptation.
- Investigation of the role of micronuclei and chromothripsis in genomic instability.
Main Results:
- Cancer cells can adapt to genotoxic stress by undergoing checkpoint adaptation, surviving, and forming micronuclei.
- Micronuclei contain damaged DNA, can replicate, and re-enter the main nucleus.
- Micronuclei are susceptible to chromothripsis, leading to extensive chromosomal rearrangements.
Conclusions:
- Checkpoint adaptation, micronuclei formation, and chromothripsis are key contributors to genomic instability in surviving cancer cells.
- Understanding these mechanisms is crucial for improving cancer treatment outcomes.
- Targeting these pathways may offer new therapeutic strategies against cancer.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

